That’s why it’s so important we speak openly about a cancer diagnosis. This year we have had a number of high profile men talking openly about their cancer. Cyclist Sir Chris Hoy, Duran Duran ...

Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...

Working with Varian, a key player in EBRT, Telix will explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment. The ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.

In May 2025, former President Joe Biden's health took a serious turn when his medical team revealed a diagnosis of aggressive ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Profound would also like to congratulate Satoru Takahashi, MD, PhD, of Takatsuki General Hospital in Japan, for receiving a Certificate of Merit award from RSNA for his presentation titled “TULSA for ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

A rare Gleason 10 prostate cancer in an 80‑year‑old veteran with a persistently low PSA… The Most EXTREME Prostate Cancer ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...